EGFR and non-small cell lung carcinoma: Therefore, sampling the MPE of NSCLC is a practical approach for investigating EGFR mutations, especially when patients present with advanced and unresectable NSCLC.[20–23] There are several testing methods available for mutational analysis in pleural fluid, including PCR direct sequencing, mutant-enriched PCR, pyrosequencing, and real-time PCR.